Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=19

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04974723-03acd85a",
        "title": "Patients Treated With ABL vs Patients Treated With TPTD: Number of Participants With a Composite Endpoint of Nonfatal MI, Nonfatal Stroke, Heart Failure or In-hospital Cardiovascular Death",
        "summary": "495 of 11027 against 471 of 11027; risk difference 0.2 points, 95% interval -0.3 to 0.8; NCT04974723, Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women",
        "record": "/library/comparisons/NCT04974723-03acd85a",
        "nct_id": "NCT04974723",
        "kind": "outcome",
        "participants": 22054,
        "risk_difference": {
          "value": 0.0021764759227351077,
          "lower": -0.0032317087442591498,
          "upper": 0.007588900875000244
        },
        "group_1": "495 of 11,027",
        "group_2": "471 of 11,027",
        "difference": "0.2 points",
        "interval": "-0.3 to 0.8",
        "trial_title": "Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women"
      },
      {
        "id": "NCT04974723-89d27107",
        "title": "Patients Treated With ABL vs Patients Treated With TPTD: Number of Participants With a Nonvertebral Fracture",
        "summary": "313 of 11027 against 333 of 11027; risk difference -0.2 points, 95% interval -0.6 to 0.3; NCT04974723, Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women",
        "record": "/library/comparisons/NCT04974723-89d27107",
        "nct_id": "NCT04974723",
        "kind": "outcome",
        "participants": 22054,
        "risk_difference": {
          "value": -0.0018137299356125874,
          "lower": -0.006278905001373819,
          "upper": 0.002645406154918809
        },
        "group_1": "313 of 11,027",
        "group_2": "333 of 11,027",
        "difference": "-0.2 points",
        "interval": "-0.6 to 0.3",
        "trial_title": "Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=20",
  "request_id": "wCZhqucuVmNqRnvv"
}